TruAlt Bioenergy Ltd

Crisil Ratings Limited’s recent report indicates that the issuer has utilized Rs 140.14 crore of the Rs 150.68 crore allocated for capital expenditure as of June 30, 2026, citing vendor invoice delays. General corporate purposes have been fully deployed, while Rs 19.46 crore remains unutilized, held in monitoring and public offer accounts at Kotak Mahindra Bank. The company plans to utilize the remaining funds in subsequent fiscal years, subject to board approval. The report, a regulatory monitoring exercise required by SEBI, relies on information provided by the issuer and third-party sources, and includes extensive disclaimers limiting Crisil’s liability and clarifying that the report does not constitute investment advice. The delay in capital expenditure and the reason for the unutilized funds warrant further scrutiny.

The company posted a sharp jump in earnings, driven by strong growth in its ethanol business and the successful integration of its dual-feed ethanol platform. The company's consolidated net profit surged 1,108.3% year-on-year to Rs 57.15 crore in Q1 FY27. On a sequential basis, net profit declined 15.8% from Rs 67.87 crore in Q4 FY26. Net sales more than doubled, rising 106.3% YoY and 5.3% QoQ to Rs 626.88 crore in Q1 FY27. EBITDA jumped 219.6% YoY to Rs 132.76 crore in Q1 FY27. Profit before tax stood at Rs 78.45 crore in Q1 FY27, up 1,252.6% YoY and down 16.8% QoQ. Total expenditure increased 88.3% YoY and 6% QoQ to Rs 494.12 crore. Raw material consumption surged 353.8% YoY to Rs 333.52 crore, while employee expenses rose 7.7% YoY to Rs 12.06 crore. Finance costs increased 16.5% YoY to Rs 44.03 crore, and depreciation expense rose 19.9% YoY to Rs 24.80 crore. Ethanol remained the company's core business, with total income nearly doubling to Rs 625.97 crore from Rs 314.60 crore a year ago. The Compressed Biogas (CBG) segment reported total income of Rs 11.31 crore, up 11.0% YoY. The Retail Fuel Network business continued to scale up, with total income jumping 132.8% YoY to Rs 4.40 crore. The company said Q1 FY27 marked the first full operational quarter following the completion of its grain integration programme. Installed ethanol capacity increased 43% to 2,000 KLPD from 1,400 KLPD a year ago, with around 1,300 KLPD, or 65% of capacity, now operating on dual-feed technology. The integrated platform enables near year-round ethanol production while improving feedstock flexibility, supply security and profitability. Grain-based operations currently deliver about 6% higher profitability than sugar-based production, while capacity utilisation stood at 60.57%, leaving room for future growth without significant capital expenditure. During the quarter, TruAlt continued expanding its clean energy portfolio. Construction progressed on four compressed biogas (CBG) plants under its joint venture with Sumitomo Corporation, while preparatory work advanced for six additional CBG plants with GAIL (India). The company also progressed its proposed 100 million litres per annum Sustainable Aviation Fuel (SAF) project in Andhra Pradesh, which has received a Rs 150 crore grant under the PM JI-VAN Yojana. It currently operates seven fuel retail outlets and plans to expand the network to 100 outlets, although the rollout has been paced due to volatility in crude oil prices. Managing director Vijay Nirani said the quarter marked an important milestone as the company began realising the benefits of its transition to a dual-feed ethanol platform. He added that the company remains focused on improving capacity utilisation and operational efficiencies while advancing its CBG, SAF and fuel retail businesses to support long-term growth. TruAlt Bioenergy is one of India's largest biofuels companies and operates an integrated bioenergy platform spanning ethanol, compressed biogas, sustainable aviation fuel, fuel retailing and value-added bio-products, supporting the country's clean energy transition. Powered by Capital Market - Live

Net profit of TruAlt Bioenergy rose 1108.25% to Rs 57.15 crore in the quarter ended June 2026 as against Rs 4.73 crore during the previous quarter ended June 2025. Sales rose 106.29% to Rs 626.88 crore in the quarter ended June 2026 as against Rs 303.89 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales626.88303.89 106 OPM %21.1813.67 - PBDT103.2526.49 290 PBT78.455.80 1253 NP57.154.73 1108 Powered by Capital Market - Live

TruAlt Bioenergy will hold a meeting of the Board of Directors of the Company on 28 July 2026.

Net profit of TruAlt Bioenergy declined 46.39% to Rs 59.88 crore in the quarter ended March 2026 as against Rs 111.69 crore during the previous quarter ended March 2025. Sales declined 34.34% to Rs 595.52 crore in the quarter ended March 2026 as against Rs 906.99 crore during the previous quarter ended March 2025. For the full year,net profit declined 34.57% to Rs 95.95 crore in the year ended March 2026 as against Rs 146.64 crore during the previous year ended March 2025. Sales declined 9.45% to Rs 1727.51 crore in the year ended March 2026 as against Rs 1907.72 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales595.52906.99 -34 1727.511907.72 -9 OPM %19.9416.95 -16.7716.21 - PBDT106.65128.41 -17 216.18226.34 -4 PBT83.70110.90 -25 129.95159.44 -18 NP59.88111.69 -46 95.95146.64 -35 Powered by Capital Market - Live

TruAlt Bioenergy will hold a meeting of the Board of Directors of the Company on 22 May 2026.

TruAlt Bioenergy today announced a strategic investment of Rs 13 crore by GAIL (India) in its subsidiary, Leafiniti Bioenergy (LBPL), marking a significant step in advancing its Compressed Biogas (CBG) portfolio and strengthening its role in India's energy transition. This investment is pursuant to the Share Subscription-cum-Shareholders' Agreement executed on 11 August  2025, under which GAIL is set to acquire 49% equity stake in Leafiniti. Under the terms of the agreement, GAIL will invest an aggregate amount of Rs 13,54,32,150 (Rs 13 crore) towards subscription of equity shares in Leafiniti, with the capital to be deployed towards new CBG projects. Post completion of the transaction, TruAlt will retain a stake of 51%, while GAIL will hold 49% equity, reflecting a balanced and strategic partnership structure. The investment is aligned with defined project approvals and governance mechanisms, ensuring disciplined capital allocation and phased scale-up of the clean gas portfolio. The collaboration represents a significant milestone in India's clean energy roadmap, combining TruAlt's expertise in bioenergy production with GAIL's extensive gas infrastructure and market reach. The joint venture will focus on establishing multiple greenfield CBG plants across Karnataka, Maharashtra, and Odisha, as part of a phased rollout designed to scale rapidly and deliver measurable environmental, economic, and social impact. In its first phase, the joint venture will roll out six state-of-the-art greenfield plants, each with a capacity of 12 tonnes per day, primarily based on associated residues from sugar mills, delivering a combined annual output of 23,976 tonnes of CBG. This buildout is expected to create approximately 820 to 1,225 direct and indirect jobs, catalysing rural employment and economic activity. In addition to clean energy, the facilities will generate high-value agricultural inputs, including 97,902 tonnes of Fermented Organic Manure (FOM) and 4,70,862 tonnes of Liquid Fermented Organic Manure (LFOM) annually. This will improve soil health and strengthen circular agriculture, ensuring that farmers become active stakeholders and beneficiaries in India's green energy transition. From an environmental perspective, the JV's first phase is projected to displace approximately 19,800 tonnes of fossil fuels annually and avoid 9,300 tonnes of methane emissions per annum, contributing meaningfully to India's climate commitments, including its net-zero by 2070 vision. Powered by Capital Market - Live

TruAlt Bioenergy will hold a meeting of the Board of Directors of the Company on 3 February 2026.Powered by Capital Market - Live

TruAlt Bioenergy has signed a non-binding Memorandum of Understanding (MoU) with the Andhra Pradesh Economic Development Board (APEDB), the Government of Andhra Pradesh's nodal agency for the establishment of a Sustainable Aviation Fuel (SAF) production plant in the State of Andhra Pradesh. The proposed project is envisaged to involve a total investment of approximately Rs 2,250 crore, to be developed in phases, subject to detailed feasibility assessments, technology evaluation, and confirmation of commercial viability. Powered by Capital Market - Live

Net Loss of TruAlt Bioenergy reported to Rs 37.94 crore in the quarter ended September 2025 as against net loss of Rs 18.66 crore during the previous quarter ended September 2024. Sales declined 70.41% to Rs 114.86 crore in the quarter ended September 2025 as against Rs 388.22 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales114.86388.22 -70 OPM %-3.964.45 - PBDT-28.39-0.17 -16600 PBT-49.18-16.26 -202 NP-37.94-18.66 -103 Powered by Capital Market - Live